FIELD: medicine.
SUBSTANCE: to implement the invention, the infiltrative component of the neoplasm is examined at the light-optical level. Alveolar, tubular, trabecular, solid structures and discrete groups of tumor cells are determined. If trabecular structures are present, a high risk of hematogenic metastasis is predicted.
EFFECT: use of the invention allows to determine the risk of hematogenic metastasing in case of non-specific invasive breast carcinoma in a certain group of patients, namely, in patients with a good response to neoadjuvant chemotherapy.
1 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HEMATOGENOUS METASTASIS PREDICTION IN CASE OF NON-SPECIFIC INVASIVE BREAST CARCINOMA FOR PATIENTS WITH BAD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2623150C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
| METHOD FOR PREDICTION OF HEMATOGENIC METASTASIS IN INVASIVE BREAST CARCINOMA OF NONSPECIFIC TYPE | 2019 |
|
RU2722274C1 |
| METHOD OF PROGNOSTICATION OF TUMOR SENSITIVITY TO NEOADJUVANT CHEMOTHERAPY FOR LUMINAL IN MOLECULAR-GENETIC TYPE OF BREAST CANCER | 2016 |
|
RU2657800C1 |
| METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
| METHOD FOR PREDICTION OF DEGREE OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LUMINAL MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2632112C1 |
| METHOD FOR PREDICTING THE DEGREE OF RISK OF DEVELOPING HEMATOGENOUS METASTASES IN INVASIVE CARCINOMA OF A NON-SPECIFIC TYPE OF MAMMARY GLAND BASED ON THE ASSESSMENT OF THE EXPRESSION OF LIMCH1 PROTEIN | 2020 |
|
RU2755242C1 |
| METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
| METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
| METHOD FOR PREDICTING RISK OF LYMPHATIC CANCER SPREAD IN BREAST CANCER BASED ON YKL-39 PROTEIN GENE EXPRESSION | 2016 |
|
RU2632115C1 |
